Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

December 4, 2024

Study Completion Date

December 11, 2026

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

CFZ533

s.c.

DRUG

Placebo to CFZ533

s.c.

DRUG

LYS006

p.o.

DRUG

Placebo to LYS006

p.o.

DRUG

MAS825

s.c.

DRUG

Placebo to MAS825

s.c.

DRUG

LOU064 25mg

p.o.

DRUG

LOU064 100mg

p.o.

DRUG

Placebo to LOU064

p.o.

DRUG

VAY736

s.c.

DRUG

Placebo to VAY736

s.c.

Trial Locations (36)

201

Novartis Investigative Site, Kopavogur

1070

Novartis Investigative Site, Brussels

2400

Novartis Investigative Site, Kobenhavn N V

4000

Novartis Investigative Site, Roskilde

4032

Novartis Investigative Site, Debrecen

7623

Novartis Investigative Site, Pécs

8036

Novartis Investigative Site, Graz

11000

Novartis Investigative Site, Prague

13885

Novartis Investigative Site, Marseille

18014

Novartis Investigative Site, Granada

19055

Novartis Investigative Site, Schwerin

20246

Novartis Investigative Site, Hamburg

29425

Medical University of South Carolina MUSC ., Charleston

30328

Advanced Medical Research, Sandy Springs

32073

Park Avenue Dermatology, PA, Orange Park

33612

University of South Florida, Tampa

33756

Olympian Clinical Research ., Clearwater

35010

Novartis Investigative Site, Las Palmas de Gran Canaria

44791

Novartis Investigative Site, Bochum

46026

Novartis Investigative Site, Valencia

46250

Dawes Fretzin Clinical Rea Group, Indianapolis

46940

Novartis Investigative Site, Manises

51100

Novartis Investigative Site, Reims

60077

NorthShore University Health System North Shore, Skokie

60590

Novartis Investigative Site, Frankfurt

69003

Novartis Investigative Site, Lyon

76031

Novartis Investigative Site, Rouen

92160

Novartis Investigative Site, Antony

17033-0850

Penn State Milton S Hershey Medical Center, Hershey

06202

Novartis Investigative Site, Nice

H-1083

Novartis Investigative Site, Budapest

H 6725

Novartis Investigative Site, Szeged

3015 GD

Novartis Investigative Site, Rotterdam

9713 GZ

Novartis Investigative Site, Groningen

08208

Novartis Investigative Site, Sabadell

08041

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY